Literature DB >> 19776687

2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?

Roger Chou1.   

Abstract

Safe and effective chronic opioid therapy (COT) for chronic noncancer pain requires clinical skills and knowledge in both the principles of opioid prescribing and in the assessment and management of risks associated with opioid abuse, addiction, and diversion. The American Pain Society and the American Academy of Pain Medicine commissioned a systematic review of the evidence on COT for chronic noncancer pain and convened a multidisciplinary expert panel to review the evidence and formulate recommendations based on the best available evidence. This article summarizes key clinical messages from this guideline regarding patient selection and risk stratification, informed consent and opioid management plans, initiation and titration of COT, use of methadone, monitoring of patients, use of opioids in high-risk patients, assessment of aberrant drug-related behaviors, dose escalations and high-dose opioid therapy, opioid rotation, indications for discontinuation of therapy, prevention and management of opioid-related adverse effects, driving and work safety, identifying a medical home and when to obtain consultation, and management of breakthrough pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776687

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  35 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  The association between prescribed opioid use for mothers and children: a record-linkage study.

Authors:  Tomas Log; Svetlana Skurtveit; Randi Selmer; Aage Tverdal; Kari Furu; Ingeborg Hartz
Journal:  Eur J Clin Pharmacol       Date:  2012-06-09       Impact factor: 2.953

Review 3.  Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions.

Authors:  Wendy M Walwyn; Karen A Miotto; Christopher J Evans
Journal:  Drug Alcohol Depend       Date:  2010-02-25       Impact factor: 4.492

4.  Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen.

Authors:  Joshua S Barclay; Justine E Owens; Leslie J Blackhall
Journal:  Support Care Cancer       Date:  2014-02-23       Impact factor: 3.603

Review 5.  Opioid Prescribing in an Opioid Crisis: What Basic Skills Should an Oncologist Have Regarding Opioid Therapy?

Authors:  Joseph Arthur; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2019-04-01

Review 6.  Facial expression and pain in the critically ill non-communicative patient: state of science review.

Authors:  Mamoona Arif-Rahu; Mary Jo Grap
Journal:  Intensive Crit Care Nurs       Date:  2010-11-03       Impact factor: 3.072

7.  Patterns of care and side effects for patients prescribed methadone for treatment of chronic pain.

Authors:  Tara A Macey; Melissa B Weimer; Elizabeth M Grimaldi; Steven K Dobscha; Benjamin J Morasco
Journal:  J Opioid Manag       Date:  2013 Sep-Oct

8.  UNDERSTANDING HOW PRIMARY CARE CLINICIANS MAKE SENSE OF CHRONIC PAIN.

Authors:  Laura G Militello; Shilo Anders; Sarah M Downs; Julie Diiulio; Elizabeth C Danielson; Robert W Hurley; Christopher A Harle
Journal:  Cogn Technol Work       Date:  2018-05-30       Impact factor: 2.372

9.  A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic.

Authors:  Nur F Önen; Ernie-Paul Barrette; Enbal Shacham; Toshibumi Taniguchi; Michael Donovan; Edgar T Overton
Journal:  Pain Pract       Date:  2011-11-22       Impact factor: 3.183

Review 10.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.